Materias dentro de su búsqueda.
Materias dentro de su búsqueda.
Hepatitis B
2
Química clínica
2
Aspectos moleculares
1
Carcinogénesis química
1
Cáncer
1
Difteria
1
Enfermedades transmisibles
1
Epidemiología
1
Español
1
Hepatitis
1
Hepatitis A.
1
Hepatitis B.
1
Hepatitis C
1
Influenza
1
Inglés
1
Modelos matemáticos
1
Prevención y control
1
Tetanos
1
Tos Ferina
1
Tétanos
1
-
15321por Gupta, Amita, Anand, Shuchi, Sastry, Jayagowri, Krisagar, Anandini, Basavaraj, Anita, Bhat, Shreepad M, Gupte, Nikhil, Bollinger, Robert C, Kakrani, Arjun L“…There were no HIV or Hepatitis B seroconversions identified. Extended PEP was continued unnecessarily in 7 (35%) of 20 cases who were confirmed to be HIV-negative. …”
Publicado 2008
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
15322“…METHODOLOGY/PRINCIPAL FINDINGS: Here we identify a new core promoter element XCPE2 (X core promoter element 2) (consensus sequence: A/C/G-C-C/T-C-G/A-T-T-G/A-C-C/A(+1)-C/T) that can direct specific transcription from the second TSS of hepatitis B virus X gene mRNA. XCPE2 sequences can also be found in human promoter regions and typically appear to drive one of the start sites within multiple TSS-containing TATA-less promoters. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
15323por Rodrigues, Junia, Grinsztejn, Beatriz, Bastos, Francisco I, Velasque, Luciane, Luz, Paula M, de Souza, Claudia TV, Georg, Ingebourg, Pilotto, Jose H, Veloso, Valdilea G“…Factors independently associated with HSV-2 seroprevalence in the multivariate model were: older age (≥ 26 years, PR: 1.41 95% Confidence Interval: 1.11–1.78), non-white race (PR: 1.32 95%CI: 1.06–1.64), positive serology for syphilis (PR: 1.65 95%CI: 1.33–2.05), positive serology for hepatitis B (PR: 1.25 95%CI: 0.99–1.57), stable male partner in the past 6 months (PR: 1.42 95%CI: 1.12–1.79), and unprotected anal sex with a stable female partner (PR: 1.46 95%CI: 1.05–2.04) in the 6 months preceding the cross-sectional assessment. …”
Publicado 2009
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
15324por Zhang, Dake, Ma, Sufang, Zhang, Xin, Zhao, Hanqing, Ding, Huiguo, Zeng, Changqing“…BACKGROUND: Mutations in the basic core promoter (BCP) and its adjacent precore (preC) region in HBV genome are common in chronic hepatitis B patients. However, the patterns of mutation combinations in these two regions during chronic infection are less understood. …”
Publicado 2010
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
15325por Gui, Junhao, Tian, Yaping, Wen, Xinyu, Zhang, Wenhui, Zhang, Pengjun, Gao, Jing, Run, Wei, Tian, Liyuan, Jia, Xingwang, Gao, Yanhong“…Five miRNAs (i.e. miR-885-5p, miR-574-3p, miR-224, miR-215 and miR-146a) that were up-regulated in the HCC and LC serum pools were selected and further quantified using real-time qPCR in patients with HCC, LC, CHB (chronic hepatitis B) or GC (gastric cancer) and in normal controls. …”
Publicado 2010
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
15326“…RESULTS: At 24 weeks, the following vaccinations had been received: bacille Calmette-Guérin (BCG): 92%; polio-1: 91%; Diphteria-Pertussis-Tetanus-Hepatitis B-Haemophilus Influenza b (DPT-HB-Hib) 3 and polio-3: 63%. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
15327por Zhou, Jialun, Sirisanthana, Thira, Kiertiburanakul, Sasisopin, Chen, Yi-Ming A, Han, Ning, Lim, Poh_Lian, Kumarasamy, Nagalingeswaran, Choi, Jun Yong, Merati, Tuti Parwati, Yunihastuti, Evy, Oka, Shinichi, Kamarulzaman, Adeeba, Phanuphak, Praphan, Lee, Christopher KC, Li, Patrick CK, Pujari, Sanjay, Saphonn, Vanthanak, Law, Matthew G“…In the final model, CD4 count slope was associated with age, concurrent HIV VL and CD4 count, disease stage, hepatitis B or C co-infection, and time since cART initiation. …”
Publicado 2010
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
15328por Arnold, David T, Bentham, Louise M, Jacob, Ruth P, Lilford, Richard J, Girling, Alan J“…RESULTS: Of the 1,236 study patients with an abnormal LFT, 13 had chronic viral hepatitis (nine hepatitis B and four hepatitis C). The strategy advocated by the current guidelines (repeating the LFT with a view to testing for specific disease if it remained abnormal) was less efficient (more expensive per case detected) than a simple policy of testing all patients for viral hepatitis without repeating LFTs. …”
Publicado 2011
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
15329“…METHODS: Cryopreserved serum samples of all subjects aged 5 to 60 years from two randomly selected rural villages in Zhejiang province in Eastern China who had participated in the China national seroepidemiological survey of hepatitis B virus (HBV) infection conducted in 2006 were tested. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
15330por Stokx, Jocelijn, Gillet, Philippe, De Weggheleire, Anja, Casas, Esther C, Maendaenda, Rosa, Beulane, Adelino J, Jani, Ilhes V, Kidane, Solon, Mosse, Carla D, Jacobs, Jan, Bottieau, Emmanuel“…BACKGROUND: The World Health Organization recommends universal and quality-controlled screening of blood donations for the major transfusion-transmissible infections (TTIs): human immunodeficiency virus (HIV), hepatitis B virus (HBV), hepatitis C virus (HCV) and syphilis. …”
Publicado 2011
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
15331por Quaranta, Alessia, Napoli, Christian, Fasano, Fabrizio, Montagna, Claudio, Caggiano, Giuseppina, Montagna, Maria Teresa“…AIDS was indicated as a possible infection by 60.3% of freshmen, hepatitis C by 38.2%, tetanus by 34.3% and hepatitis B by 33.7% of the sample. 28.1% of freshmen were not aware that there are also non-infectious complications. 29% of the sample had at least one piercing or tattoo (this percentage does not include earlobe piercing in women). …”
Publicado 2011
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
15332por Audsley, Jennifer, Seaberg, Eric C., Sasadeusz, Joe, Matthews, Gail V., Avihingsanon, Anchalee, Ruxrungtham, Kiat, Fairley, Kit, Finlayson, Robert, Hwang, Hyon S., Littlejohn, Margaret, Locarnini, Stephen, Dore, Gregory J., Thio, Chloe L., Lewin, Sharon R.“…BACKGROUND: Previous studies have demonstrated that hepatitis B virus (HBV) infection increases the risk for ALT elevations in HIV-HBV co-infected patients during the first year of HAART; however, there is limited data on the prevalence of ALT elevations with prolonged HAART in this patient group. …”
Publicado 2011
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
15333por Liu, Angela M, Yao, Tzy-Jyun, Wang, Wei, Wong, Kwong-Fai, Lee, Nikki P, Fan, Sheung Tat, Poon, Ronnie T P, Gao, Chunfang, Luk, John M“…PARTICIPANTS: The exploration phase included 96 patients with HCC who received primary curative hepatectomy, and the validation phase included 29 hepatitis B carriers, 57 patients with HCC and 30 healthy controls. …”
Publicado 2012
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
15334por Lifson, Alan R, Krantz, Elizabeth M, Grambsch, Patricia L, Macalino, Grace E, Crum-Cianflone, Nancy F, Ganesan, Anuradha, Okulicz, Jason F, Eaton, Anne, Powers, John H, Eberly, Lynn E, Agan, Brian K“…CD4+ ≥ 500, HR = 2.97), greater HIV RNA level (HR = 1.36 per one log(10 )increase), hepatitis C antibody or chronic hepatitis B (HR = 1.96), and HIV diagnosis before 1996 (HR = 2.44). …”
Publicado 2012
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
15335por Vermehren, Johannes, Vermehren, Annika, Mueller, Axel, Carlebach, Amina, Lutz, Thomas, Gute, Peter, Knecht, Gaby, Sarrazin, Christoph, Friedrich-Rust, Mireen, Forestier, Nicole, Poynard, Thierry, Zeuzem, Stefan, Herrmann, Eva, Hofmann, Wolf Peter“…BACKGROUND: Liver fibrosis in human immunodeficiency virus (HIV)-infected individuals is mostly attributable to co-infection with hepatitis B or C. The impact of other risk factors, including prolonged exposure to combined antiretroviral therapy (cART) is poorly understood. …”
Publicado 2012
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
15336por Kwong, Jeffrey C., Ratnasingham, Sujitha, Campitelli, Michael A., Daneman, Nick, Deeks, Shelley L., Manuel, Douglas G., Allen, Vanessa G., Bayoumi, Ahmed M., Fazil, Aamir, Fisman, David N., Gershon, Andrea S., Gournis, Effie, Heathcote, E. Jenny, Jamieson, Frances B., Jha, Prabhat, Khan, Kamran M., Majowicz, Shannon E., Mazzulli, Tony, McGeer, Allison J., Muller, Matthew P., Raut, Abhishek, Rea, Elizabeth, Remis, Robert S., Shahin, Rita, Wright, Alissa J., Zagorski, Brandon, Crowcroft, Natasha S.“…The most burdensome infectious agents were: hepatitis C virus, Streptococcus pneumoniae, Escherichia coli, human papillomavirus, hepatitis B virus, human immunodeficiency virus, Staphylococcus aureus, influenza virus, Clostridium difficile, and rhinovirus. …”
Publicado 2012
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
15337por Keppeke, Gerson Dierley, Nunes, Eunice, Ferraz, Maria Lucia Gomes, Silva, Eduardo Antônio Benedito, Granato, Celso, Chan, Edward K. L., Andrade, Luís Eduardo C.“…Anti-RR was detected in 14.1% of 342 HCV patients, 9.1% of 55 HCV/HIV, 3.4% of 29 Hepatitis B, and none of 171 non-HCV (p<0.0001; HCV versus non-HCV). …”
Publicado 2012
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
15338por Swart, Alexander, Burns, Lucinda, Mao, Limin, Grulich, Andrew E, Amin, Janaki, O'Connell, Dianne L, Meagher, Nicola S, Randall, Deborah A, Degenhardt, Louisa, Vajdic, Claire M“…OBJECTIVE: To quantify cancer risk in opioid dependence and the association with infection by the oncogenic blood-borne viruses (BBVs) hepatitis C (HCV), hepatitis B (HBV) and HIV. DESIGN: Cohort study. SETTING: New South Wales, Australia. …”
Publicado 2012
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
15339por Petta, Salvatore, Macaluso, Fabio Salvatore, Barcellona, Maria Rosa, Cammà, Calogero, Cabibi, Daniela, Di Marco, Vito, Craxì, Antonio“…In patients with nonalcoholic fatty liver disease (NAFLD), genotype 1 chronic hepatitis C (G1CHC) and chronic hepatitis B (CHB), we assessed the link between liver fibrosis and γ-GT serum levels, and we evaluated if normal or high γ-GT serum levels affect the association between insulin resistance (IR) and severity of liver fibrosis. …”
Publicado 2012
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
15340por Mayinuer, Abudureheman, Yasen, Mahmut, Mogushi, Kaoru, Obulhasim, Gulanbar, Xieraili, Maimaiti, Aihara, Arihiro, Tanaka, Shinji, Mizushima, Hiroshi, Tanaka, Hiroshi, Arii, Shigeki“…RESULTS: According to the microarray profiles, PTP4A3/PRL-3 was upregulated in patients with poorly differentiated disease compared to patients with well-differentiated disease with hepatic backgrounds associated with hepatitis B or C. Validation analysis showed that the PTP4A3/PRL-3 mRNA and protein levels were significantly associated with poor differentiation (P < 0.0001), high serum α-fetoprotein (P < 0.01), high serum protein induced by vitamin K absence/antagonist-II (PIVKA-II), and hepatic vascular invasion (P < 0.05). …”
Publicado 2012
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto